CLASS II Device recall · Reported 7 Jan 2015 · FDA Enforcement Report

Accu-chek Tender I 17/60 recalled by Roche Diagnostics Operations

Roche Diagnostics Operations is recalling Accu-chek Tender I 17/60, distributed nationwide in the US. The recall was initiated on 20 Nov 2014 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesCatalog: 04541430001 and lots: 5040425, 5044367, 5051305, 5053294, and 5061932.
Quantity recalledTotal of 13,041 boxes

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0886-2015
FDA event ID
69821
Recalling firm
Roche Diagnostics Operations, Indianapolis, IN
Classification
Class II
Status
Terminated
Recall initiated
20 Nov 2014
FDA classified
30 Dec 2014
Reported
7 Jan 2015
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

20 Nov 2014Recall initiated by company
30 Dec 2014Classified by FDA+40 days
7 Jan 2015Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Roche Diabetes Care was informed by UnoMedical, the Manufacturer of ACCU-CHEK Tender I and ACCU-CHEK Tender II infusion sets, about potential for the the tubing of the infusion set to become detached at the connect/disconnect location on the ACCU-CHEK Tender I and ACCU-CHEK Tender II infusion sets. If tubing detachment occurs, insulin delivery is interrupted and the pump will not alarm to notify

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

ACCU-CHEK Tender I 17/60 10 pieces Product Usage: Intended for the infusion and/or injection of fluids into the body below the surface of the skin. The indwelling catheter can be inserted independently from the infusion catheter and can be accessed for the injections through the injection port. The indwelling catheter can also be securely attached to the infusion catheter by means of a proprietary click-lock connector for the infusion of drugs subcutaneously. The infusion set can be detached from the indwelling catheter, and the catheter capped to allow freedom from the infusion set and pump for showers, athletics or other activities.

Where it was distributed

US Nationwide Distribution

Nationwide

Questions about this recall

Is Accu-chek Tender I 17/60 recalled?

Yes. Roche Diagnostics Operations recalled Accu-chek Tender I 17/60 on 20 Nov 2014. The recall is Class II and its status is Terminated. Recall number Z-0886-2015.

Why was it recalled?

Roche Diabetes Care was informed by UnoMedical, the Manufacturer of ACCU-CHEK Tender I and ACCU-CHEK Tender II infusion sets, about potential for the the tubing of the infusion set to become detached at the connect/disconnect location on the ACCU-CHEK Tender I and ACCU-CHEK Tender II infusion sets. If tubing detachment occurs, insulin delivery is interrupted and the pump will not alarm to notify

Which lots are affected?

Catalog: 04541430001 and lots: 5040425, 5044367, 5051305, 5053294, and 5061932.

Where was it sold?

US Nationwide Distribution

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Roche Diagnostics Operations

All 127

Other Heart & Vascular Devices recalls

All 6,190